TC Energy Corp
TRP
Choice Properties Real Estate Investment Trust
CHP.UN
Enbridge Inc
ENB
Bank of Nova Scotia
BNS
Power Corporation of Canada
POW
CA Stock MarketDetailed Quotes
MDNA Medicenna Therapeutics Corp
- 1.790
- +0.070+4.07%
15min DelayMarket Closed Dec 17 16:00 ET
139.90MMarket Cap-4.71P/E (TTM)
1.800High1.680Low49.02KVolume1.720Open1.720Pre Close84.90KTurnover2.98052wk High0.10%Turnover Ratio78.16MShares0.38552wk Low-0.38EPS TTM91.23MFloat Cap7.250Historical HighLossP/E (Static)50.97MShs Float0.215Historical Low-0.37EPS LYR6.98%Amplitude--Dividend TTM6.96P/B1Lot Size--Div YieldTTM
Medicenna Therapeutics Corp Key Stats
Quarterly+Annual
YOY
| (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 1.66%5.53M | -9.40%4.04M | 14.54%18.67M | 34.67%4M | -2.93%4.78M | 33.23%5.44M | 2.98%4.46M | -27.46%16.3M | -4.99%2.97M | 0.49%4.92M |
| Selling and administrative expenses | -22.20%1.79M | -23.88%1.25M | 12.51%7.87M | 54.12%2.13M | -9.63%1.78M | 34.07%2.3M | -14.23%1.65M | -9.40%6.99M | -28.25%1.38M | -0.30%1.97M |
| -General and administrative expense | -22.20%1.79M | -23.88%1.25M | 12.51%7.87M | 54.12%2.13M | -9.63%1.78M | 34.07%2.3M | -14.23%1.65M | -9.40%6.99M | -28.25%1.38M | -0.30%1.97M |
| Research and development costs | 18.89%3.73M | -1.07%2.78M | 16.08%10.8M | 17.47%1.86M | 1.56%2.99M | 32.68%3.13M | 16.63%2.81M | -36.78%9.3M | 33.17%1.59M | 1.31%2.95M |
| Depreciation amortization depletion | 900.00%10K | 400.00%5K | 0.00%5K | ---- | 0.00%2K | -50.00%1K | --1K | -86.49%5K | -85.71%1K | -80.00%2K |
| -Depreciation and amortization | 900.00%10K | 400.00%5K | 0.00%5K | ---- | 0.00%2K | -50.00%1K | --1K | -86.49%5K | -85.71%1K | -80.00%2K |
| Operating profit | -1.66%-5.53M | 9.40%-4.04M | -14.54%-18.67M | -34.67%-4M | 2.93%-4.78M | -33.23%-5.44M | -2.98%-4.46M | 27.46%-16.3M | 4.99%-2.97M | -0.49%-4.92M |
| Net non-operating interest income (expenses) | 10.53%378K | -4.62%330K | 31.07%1.2M | -40.31%228K | -17.06%282K | 111.11%342K | 1,053.33%346K | 1,224.64%914K | 4,144.44%382K | 2,025.00%340K |
| Non-operating interest income | 10.53%378K | -4.62%330K | 31.07%1.2M | -40.31%228K | -17.06%282K | 111.11%342K | 1,053.33%346K | 1,224.64%914K | 4,144.44%382K | 2,025.00%340K |
| Other net income (expenses) | -28.21%985K | -94.16%73K | -249.60%-7.99M | -699.61%-10.13M | -114.01%-482K | -54.61%1.37M | 762.76%1.25M | 3,187.28%5.34M | -1,339.77%-1.27M | 4,548.65%3.44M |
| Gain on sale of security | -28.21%985K | -94.16%73K | -249.60%-7.99M | -699.61%-10.13M | -114.01%-482K | -54.61%1.37M | 762.76%1.25M | 3,187.28%5.34M | -1,339.77%-1.27M | 4,548.65%3.44M |
| Income before tax | -11.85%-4.16M | -27.08%-3.64M | -153.44%-25.47M | -260.58%-13.9M | -336.20%-4.98M | -315.51%-3.72M | 31.12%-2.86M | 55.49%-10.05M | -20.27%-3.86M | 76.26%-1.14M |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -11.85%-4.16M | -27.08%-3.64M | -153.44%-25.47M | -260.58%-13.9M | -336.20%-4.98M | -315.51%-3.72M | 31.12%-2.86M | 55.49%-10.05M | -20.27%-3.86M | 76.26%-1.14M |
| Net income continuous operations | -11.85%-4.16M | -27.08%-3.64M | -153.44%-25.47M | -260.58%-13.9M | -336.20%-4.98M | -315.51%-3.72M | 31.12%-2.86M | 55.49%-10.05M | -20.27%-3.86M | 76.26%-1.14M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -11.85%-4.16M | -27.08%-3.64M | -153.44%-25.47M | -260.58%-13.9M | -336.20%-4.98M | -315.51%-3.72M | 31.12%-2.86M | 55.49%-10.05M | -20.27%-3.86M | 76.26%-1.14M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -11.85%-4.16M | -27.08%-3.64M | -153.44%-25.47M | -260.58%-13.9M | -336.20%-4.98M | -315.51%-3.72M | 31.12%-2.86M | 55.49%-10.05M | -20.27%-3.86M | 76.26%-1.14M |
| Diluted earnings per share | 0.00%-0.05 | -25.00%-0.05 | -131.25%-0.37 | -233.33%-0.2 | -250.00%-0.07 | -400.00%-0.05 | 42.86%-0.04 | 61.90%-0.16 | 0.00%-0.06 | 77.78%-0.02 |
| Basic earnings per share | 0.00%-0.05 | -25.00%-0.05 | -131.25%-0.37 | -233.33%-0.2 | -250.00%-0.07 | -400.00%-0.05 | 42.86%-0.04 | 61.90%-0.16 | 0.00%-0.06 | 77.78%-0.02 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.